Delivery Order SPE2DB22D1202-SPE2DB24FUJG0
Award Date 12/1/23
Potential Completion Date 12/4/23
Potential Value $36K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of a specific pharmaceutical product, Rinvoq ER 15 mg tablets, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,585.33 and a completion date of September 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Rinvoq ER 15 mg tablets. The contract award has a ceiling value of $81,502.70 and is a firm fixed price delivery order with a completion date of January 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $23,003.57, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 9, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $24,780.28, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier to various government agencies,...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $13,155.21 and a period of performance through January 29, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $103,839.94, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of January 4, 2024. The contract was not set aside for any specific business size or type....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Rinvoq ER 15 mg tablet. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,016.67 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for $11,541.19. The contract has an ultimate completion date of May 2, 2023 and is a firm-fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of Rinvoq ER 45 mg tablets to the Defense Logistics Agency (DLA). The $29,975.83 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The award has an ultimate completion date of October 30, 2023 and was not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,495.84 firm fixed price delivery order has a completion date of January 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for delivering a...